What is Restasis MultiDose?
Restasis MultiDose is a prescription medication used to treat chronic dry eye. It is an ophthalmic emulsion containing the active ingredient cyclosporine, which works by increasing the eyes' natural ability to produce tears. Chronic dry eye is a condition in which the eyes do not produce enough tears or the tears evaporate too quickly, leading to discomfort, irritation, and sometimes damage to the cornea.
Restasis MultiDose is administered by putting one drop into each eye twice a day, with a 12-hour interval between doses. It comes in a multidose bottle, which means that one bottle can be used to dispense multiple doses. This makes Restasis MultiDose a convenient option for those who need to use the medication regularly.
Restasis MultiDose is the only preservative-free prescription eye drop in the U.S. that is offered in a multidose bottle. It has been approved by the U.S. Food and Drug Administration (FDA) as a safe and effective treatment for chronic dry eye. Restasis MultiDose has been shown to significantly improve the symptoms of chronic dry eye, including eye dryness, irritation, and discomfort.
Like all medications, Restasis MultiDose can cause side effects. The most common side effect is a temporary burning or itching sensation in the eyes immediately after using the medication. Other potential side effects include redness, discharge, and blurred vision. These side effects usually go away on their own and do not require medical attention.
If you are experiencing symptoms of chronic dry eye, it is important to consult with an eye doctor. They can diagnose the condition and recommend appropriate treatment, which may include Restasis MultiDose. As with any medication, it is important to follow the instructions of your healthcare provider and to report any side effects that you may experience.
Frequently Asked Questions about restasis multidose
It's the same preservative-free RESTASIS® formulation doctors have prescribed 6.4 million times since 2003,* in a patented bottle design. Compared to RESTASIS® single-use vials, RESTASIS MultiDose ® is more compact, uses less plastic in packaging, and is the same price in comparison to a package of single-use vials.
RESTASIS® and RESTASIS MultiDose ® Ophthalmic Emulsion help increase your eyes' natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye.
One drop of Restasis MultiDose should be administered into each eye twice daily, amounting to 4 drops total, which means that one bottle should last a little longer than 30 days. For a 90-day supply, patients will be given 3 bottles at a time.
ophthalmic emulsion contains: Active: cyclosporine 0.05%. Inactives: glycerin; castor oil; polysorbate 80; carbomer copolymer type A; purified water; and sodium hydroxide to adjust pH.
One bottle of Restasis MultiDose (cyclosporine ophthalmic emulsion) contains a little over 120 doses/drops. One drop of Restasis MultiDose should be administered into each eye twice daily, amounting to 4 drops total, which means that one bottle should last a little longer than 30 days.
However, one common cause for higher consumer cost is a lack of competition. Restasis is a brand-name drug. These drugs are often under patent when first released, meaning no one else can manufacture them. So they are frequently priced higher initially due to a lack of similar medications vying for the same market.
One bottle of Restasis MultiDose (cyclosporine ophthalmic emulsion) contains a little over 120 doses/drops. One drop of Restasis MultiDose should be administered into each eye twice daily, amounting to 4 drops total, which means that one bottle should last a little longer than 30 days.
The RESTASIS ®and RESTASIS MultiDose ® list price is $645.63 † per month, plus any additional pharmacy charges depending on where you purchase your medicine.
Similar to brand-name Restasis, this generic version is available as packs of 30 and 60 single-use vials, containing 0.5 mg of cyclosporine in every 1 mL. Keep in mind, there still isn't a generic available for the multiple use bottle, Restasis MultiDose.
Yes, you will receive three 5.5-mL multidose bottles, which are intended for a 90-day supply.
The class action complaint alleges that Allergan unlawfully extended its monopoly in the market for Restasis through a series of fraudulent and anticompetitive acts, including: Committing fraud on the U.S. Patent and Trademark Office to gain approval for a second wave of patents extending Allergan's Restasis monopoly.
The RESTASIS ®and RESTASIS MultiDose ® list price is $645.63 † per month, plus any additional pharmacy charges depending on where you purchase your medicine.
Thirty single-use vials provide a 15-day supply, while 60 vials provide a 30-day supply. Restasis is the same price whether it is supplied in multidose bottles or single-use vials. Prices will vary depending on the pharmacy and your insurance coverage.
One bottle of Restasis MultiDose (cyclosporine ophthalmic emulsion) contains a little over 120 doses/drops. One drop of Restasis MultiDose should be administered into each eye twice daily, amounting to 4 drops total, which means that one bottle should last a little longer than 30 days.
The RESTASIS® list price, also known as the wholesale acquisition cost (WAC), 1 iS $645.63 † for a 30-day supply of RESTASIS® or RESTASIS MultiDose®. Call 1.844. 4MY-TEARS (1-844-469-8327) to find how much RESTASIS® will cost for you.
If you would prefer to not discard leftover medication, ask for RESTASIS MultiDose ®. It is the same RESTASIS® formulation in a bottle. The patented RESTASIS MultiDose ® is the only FDA-approved, preservative-free medication in a bottle.
